Redrado M - Search Results

1

Biomarkers and polymorphisms in pancreatic neuroendocrine tumors treated with sunitinib.

Jiménez-Fonseca P, Martín MN, Carmona-Bayonas A, Calvo A, Fernández-Mateos J, Redrado M, Capdevila J, Lago NM, Lacasta A, Muñarriz J, Segura Á, Fuster J, Barón F, Llanos M, Serrano R, Castillo A, Cruz Hernández JJ, Grande E. Jiménez-Fonseca P, et al. Among authors: redrado m. Oncotarget. 2018 Dec 11;9(97):36894-36905. doi: 10.18632/oncotarget.26380. eCollection 2018 Dec 11. Oncotarget. 2018. PMID: 30651923 Free PMC article.

2

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model.

Diaz R, Nguewa PA, Parrondo R, Perez-Stable C, Manrique I, Redrado M, Catena R, Collantes M, Peñuelas I, Díaz-González JA, Calvo A. Diaz R, et al. Among authors: redrado m. BMC Cancer. 2010 May 11;10:188. doi: 10.1186/1471-2407-10-188. BMC Cancer. 2010. PMID: 20459769 Free PMC article.

3

Selenoprotein-P is down-regulated in prostate cancer, which results in lack of protection against oxidative damage.

Gonzalez-Moreno O, Boque N, Redrado M, Milagro F, Campion J, Endermann T, Takahashi K, Saito Y, Catena R, Schomburg L, Calvo A. Gonzalez-Moreno O, et al. Among authors: redrado m. Prostate. 2011 Jun 1;71(8):824-34. doi: 10.1002/pros.21298. Epub 2010 Nov 17. Prostate. 2011. PMID: 21456065

4

Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance.

Ponz-Sarvisé M, Nguewa PA, Pajares MJ, Agorreta J, Lozano MD, Redrado M, Pio R, Behrens C, Wistuba II, García-Franco CE, García-Foncillas J, Montuenga LM, Calvo A, Gil-Bazo I. Ponz-Sarvisé M, et al. Among authors: redrado m. Clin Cancer Res. 2011 Jun 15;17(12):4155-66. doi: 10.1158/1078-0432.CCR-10-3381. Epub 2011 May 3. Clin Cancer Res. 2011. PMID: 21540238

5

Therapeutic effect of lenalidomide in a novel xenograft mouse model of human blastic NK cell lymphoma/blastic plasmacytoid dendritic cell neoplasm.

Agliano A, Martin-Padura I, Marighetti P, Gregato G, Calleri A, Prior C, Redrado M, Calvo A, Bertolini F. Agliano A, et al. Among authors: redrado m. Clin Cancer Res. 2011 Oct 1;17(19):6163-73. doi: 10.1158/1078-0432.CCR-11-0212. Epub 2011 Aug 19. Clin Cancer Res. 2011. PMID: 21856771

6

Epithelial to mesenchymal transition and cancer stem cell phenotypes leading to liver metastasis are abrogated by the novel TGFβ1-targeting peptides P17 and P144.

Zubeldia IG, Bleau AM, Redrado M, Serrano D, Agliano A, Gil-Puig C, Vidal-Vanaclocha F, Lecanda J, Calvo A. Zubeldia IG, et al. Among authors: redrado m. Exp Cell Res. 2013 Feb 1;319(3):12-22. doi: 10.1016/j.yexcr.2012.11.004. Epub 2012 Nov 12. Exp Cell Res. 2013. PMID: 23153552

7

Spatial-temporal protein expression of inhibitor of differentiation-1 (Id1) during fetal embryogenesis and in different mouse and human cancer types.

Redrado M, Bodegas E, Villaro AC, Nguewa PA, Lopez I, Gil-Bazo I, Calvo A. Redrado M, et al. Histol Histopathol. 2013 Aug;28(8):1029-40. doi: 10.14670/HH-28.1029. Epub 2013 Apr 5. Histol Histopathol. 2013. PMID: 23558671

8

Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications.

Ponz-Sarvisé M, Castañón E, Panizo-Santos A, Redrado M, López I, Rosell D, Gil-Aldea I, Calvo A, Nguewa PA, Gil-Bazo I. Ponz-Sarvisé M, et al. Among authors: redrado m. Clin Genitourin Cancer. 2014 Apr;12(2):87-93. doi: 10.1016/j.clgc.2013.08.007. Epub 2013 Oct 12. Clin Genitourin Cancer. 2014. PMID: 24129125

9

Differential effects of drugs targeting cancer stem cell (CSC) and non-CSC populations on lung primary tumors and metastasis.

Larzabal L, El-Nikhely N, Redrado M, Seeger W, Savai R, Calvo A. Larzabal L, et al. Among authors: redrado m. PLoS One. 2013 Nov 20;8(11):e79798. doi: 10.1371/journal.pone.0079798. eCollection 2013. PLoS One. 2013. PMID: 24278179 Free PMC article.

10

Id-1B, an alternatively spliced isoform of the inhibitor of differentiation-1, impairs cancer cell malignancy through inhibition of proliferation and angiogenesis.

Nguewa P, Manrique I, Díaz R, Redrado M, Parrondo R, Perez-Stable C, Calvo A. Nguewa P, et al. Among authors: redrado m. Curr Mol Med. 2014 Jan;14(1):151-62. doi: 10.2174/1566524013666131203100643. Curr Mol Med. 2014. PMID: 24295493

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page